Bioethics Education International (BEI) advances policy and intercultural bioethics debates from the beginning to the end of life.
Who We Are
BEI is a 501c3 tax exempt not-for-profit international organization incorporated in the State of New York, located in Manhattan.
Who will benefit from BEI’s programs and activities?
The organization benefits students, professionals and policy makers from various fields, such as healthcare, the humanities, and the law, as well as policy makers and the public at large. It aims to provide stakeholders with resources to understand and find solutions to issues in global health, health care, new medical technologies, and the life sciences.
How will BEI achieve its educational and outreach purposes?
Through an online bioethics hub, BEI is offering engaging and interactive e-learning courses, webinars, and training sessions. The hub will offer timely topics in bioethics in creative ways, incorporating an interdisciplinary and intercultural approach to confronting ethical issues in medicine, bioscience, medical technology, life sciences, and the environment. BEI provides public access to international bioethics education, facilitates collaborative learning, networking and community debates across the life course around the globe.
News and Articles
A Public Health Milestone in Eliminating Leprosy
Chile has eliminated leprosy, becoming the first country in the Americas to reach this public health milestone. Leprosy, also known as Hansen’s disease, is a neglected tropical disease that affects the skin and nerves. The [...]
Artificial Wombs and the Future of Neonatal Care
Scientists are developing synthetic womb technology that could support extremely premature infants outside the human body. The innovation has the potential to improve survival rates and reduce complications associated with premature birth by allowing continued [...]
When Prevention Protects the Next Generation: A Milestone in Maternal and Infant Health
Denmark has become the first country in the European Union to eliminate mother-to-child transmission of HIV and syphilis, marking an important milestone in maternal and public health. The achievement reflects decades of strong prenatal care [...]
Patient Safety in the Age of Digital Prescribing
The FDA recently warned about 30 telehealth companies for marketing compounded GLP-1 drugs for weight loss. These medications are not FDA-approved and may be promoted in ways that could mislead patients. The situation raises concerns [...]